GETTING THE CONVERSATION GOING ON THE CONNECTION BETWEEN ORAL HEALTH AND CHRONIC CONDITIONS
With
Dr Carol Tran, Oral Health Therapist &
Scientific Program Chair,
Oral Health Association of Australia (OHAA) Congress &
Past President, Dental Hygienists Association of Australia (DHAA) &
Co-director, Oral Health Home
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Brisbane | September 2025
Dr. Carol Tran is an Oral Health Therapist and co-founder of Oral Health Home, an organisation focused on innovative, prevention-oriented oral health education and outreach. She is a Past President of Dental Hygienists Association of Australia (DHAA) and currently is the Scientific Program Chair, for upcoming congress in October 2025, for the newly formed Oral Health Association of Australia (OHAA).
A pivotal moment in Dr. Tran’s career was her leadership work with the DHAA. Throughout her tenure, she has served as a Director and President, leading national advocacy strategies and chairing committees on governance and special needs dentistry. One of her major achievements was successfully campaigning for oral health therapists, dental hygienists, and dental therapists to receive provider numbers, enabling them to be recognised as Medicare health care providers in their own right. This experience helped shape her belief in the potential for oral health practitioners to drive broader healthcare reform, ultimately inspiring her to co-found Oral Health Home.
Dr. Tran enjoys making oral health accessible and meaningful, particularly for often-overlooked communities. Currently, she is piloting a chewing and oral hypofunction program in aged care that uses technology to enhance residents’ oral function, alongside collaborating with CSIRO on food engineering research. She observes a growing awareness of the connection between oral health and overall wellness, but acknowledges ongoing challenges such as workforce shortages and fragmented funding. For those looking to enter this sector, she advises aspiring professionals to advocate, innovate, and think beyond traditional clinical roles.
Source: Adapted from supplied text
-
Changes in MBS bulk billing incentives address GP capacity in women’s health
Dr. Sneha Wadhwani, a General Practitioner in Bondi, and Conjoint Lecturer at UNSW School of Medicine, is actively involved in enhancing women’s health services across Australia. As the Co-founder and Clinical Director of Evoca Women’s Health, she highlights the significant improvements in funding for women’s health, particularly with the new MBS bulk billing incentives, in new codes, that commenced on November 1, 2025.
-
From paediatric nursing to leadership & private hospital general management
With over 20 years of experience in the Australian and international healthcare sectors, Georgia Banks is a dedicated and results-driven health professional with a proven track record in clinical, financial, human resources, and strategic management. Passionate about delivering high-quality patient care, Georgia possesses an authentic leadership style that fosters engagement, collaboration, and continuous improvement.
Currently serving as General Manager at Hobart Private Hospital within Healthscope, Georgia has been instrumental in driving operational excellence, enhancing patient experience, and supporting staff development. Her leadership has played a key role in aligning hospital services with strategic priorities while fostering a culture of accountability and innovation.
-
Bionic eye trial shows improvements in functional vision for retinitis pigmentosa
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
